Skip to main content
Veterinary Medicines

Hipragumboro G97 Lyophilisate for Oral Suspension for Chickens

Authorised
  • Infectious bursal disease virus, strain GM97, Live

Product identification

Medicine name:
HIPRAGUMBORO-G97
Hipragumboro G97 Lyophilisate for Oral Suspension for Chickens
Active substance:
  • Infectious bursal disease virus, strain GM97, Live
Target species:
  • Chicken (broiler)
  • Chicken (one day-old chick)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain GM97, Live
    100.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Oral use
    • Chicken (broiler)
      • All relevant tissues
        0
        day
    • Chicken (one day-old chick)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • Pack with 1 vial of 1000 doses
  • Pack with 10 vials of 5000 doses
  • Pack with 10 vials of 1000 doses
  • Pack with 1 vial of 5000 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 17533/3008
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0352/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)